You just read:

Sorrento Therapeutics Announces the Completion of GMP Manufacturing Plant in Suzhou, China to Support its Growing Antibody-Drug Conjugate (ADC) Pipeline and Service Business

News provided by

Sorrento Therapeutics, Inc.

04 May, 2017, 09:41 ET